HRT Financial’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
2025
Q1
$3.09M Buy
2024
Q4
$339K Buy
2024
Q2
Sell
2024
Q1
$4.73M Buy
2023
Q3
Sell
2023
Q2
$791K Sell
2023
Q1
$1.6M Buy
2022
Q4
$572K Buy
2021
Q3
Sell
2021
Q2
$16.5M Buy
2021
Q1
$1.28M Buy
2020
Q3
Sell
2020
Q2
$276K Buy
2019
Q1
Sell
2018
Q4
$296K Buy